JMIR Diabetes Impact Factor in Biomedical Engineering

JMIR Diabetes in Biomedical Engineering

Journal Country: Canada
Journal Q tier: Q2
Publishing Firm: JMIR Publications Inc.
History: 2016-2022
Journal Homepage: ----
Journal ISSN: 23714379

Research Categories

Biomedical Engineering (Q2); Endocrinology, Diabetes and Metabolism (Q3); Health Informatics (Q3); Health Information Management (Q3)

Impact Score: 2.5
h-Index: 17
SJR: 0.643
Ranking: 7922

About JMIR Diabetes

JMIR Diabetes is a journal covering the technologies/fields/categories related to Biomedical Engineering (Q2); Endocrinology, Diabetes and Metabolism (Q3); Health Informatics (Q3); Health Information Management (Q3). It is published by JMIR Publications Inc.. The overall rank of JMIR Diabetes is 7922.According to SCImago Journal Rank (SJR), this journal is ranked 0.643. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 17. The best quartile for this journal is Q2.The ISSN of JMIR Diabetes journal is 23714379.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. JMIR Diabetes is cited by a total of 240 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.